CARMIL2 and autoimmune disease: Impaired regulatory T-cell development can increase the risk of autoimmune disease in human patients with CARMIL2 deficiencies [31,33], and one CKCS also suffered from MMM, an inflammatory myopathy that occurs when autoantibodies against 2M myofibers are produced.